MyAverix Finance
NS · Pharmaceuticals
Emcure Pharmaceuticals Ltd (EMCURE)
Pharmaceuticals & Biotechnology
Emcure Pharmaceuticals Ltd (EMCURE) is listed on NS in the Pharmaceuticals sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $344.83B, P/E ratio is 47.05, dividend yield is 0.16%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for EMCURE
Emcure Pharmaceuticals Ltd (EMCURE) — FAQ
What is Emcure Pharmaceuticals Ltd's market cap?
Emcure Pharmaceuticals Ltd (EMCURE) has a reported market cap of $344.83B (data as of 2026-07-10).
What is EMCURE's P/E ratio?
The price-to-earnings (P/E) ratio for Emcure Pharmaceuticals Ltd (EMCURE) is 47.05 (data as of 2026-07-10).
Does Emcure Pharmaceuticals Ltd pay a dividend?
Emcure Pharmaceuticals Ltd (EMCURE) shows a reported dividend yield of 0.16%. Open the MyAverix Finance app for dividend history and payout details (data as of 2026-07-10).
What sector is Emcure Pharmaceuticals Ltd in?
Emcure Pharmaceuticals Ltd (EMCURE) is classified in the Pharmaceuticals sector (Pharmaceuticals & Biotechnology industry).
What exchange is EMCURE listed on?
EMCURE is listed on NS.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.